We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Fungus-Associated Bacteriome Associated with C. difficile Infection

By LabMedica International staff writers
Posted on 11 Sep 2019
Clostridioides difficile infection (CDI), the most common etiology of nosocomial infectious diarrhea, is caused by an intestinal dysbiosis that is virtually always attributable to antibiotics. More...
This causes one of the most common hospital-acquired infections in the USA.

There is a growing body of data showing that distinct bacterial and fungal community structures distinguish the dysbiotic state of CDI from antibiotic-associated diarrhea due to other causes. The data suggests that transkingdom interactions between fungal and bacterial species play an important role in nosocomial infections.

A team of scientists collaborating with the University of Arizona (Tucson, AZ, USA) collected diarrheal stools from 49 inpatients (18 of whom tested positive for CDI) under stringent inclusion criteria. C. difficile testing was performed using a commercially available nucleic acid amplification test designed to detect a highly conserved sequence within the tcdA gene. C. difficile positive and negative stool samples were preserved.

Fecal DNA extracts were subject to 16S rRNA gene and ITS2 Illumina tag polymerase chain reaction (PCR) (Illumina, San Diego, CA, USA; www.illumina.com), pooled in equimolar ratios, gel purified, and sequenced on the Illumina MiSeq (16S rRNA libraries) and NextSeq (ITS libraries) platforms. Bacterial (16S rRNA gene) and fungal (ITS) sequences were quality filtered, clustered into operational taxonomic units (OTUs), and normalized using both the USEARCH and QIIME pipelines. The team utilized a tiered sequencing approach to identify enriched bacterial and fungal taxa, using 16S and internal transcribed spacer (ITS) rRNA gene amplicon sequencing, with matched metagenomics and metatranscriptomics performed on a subset of the population.

The scientists reported that distinct bacterial and fungal compositions distinguished CDI-positive and -negative patients, with the greatest differentiation between the cohorts observed based on bacterial metatranscriptomics. Bipartite network analyses demonstrated that Aspergillus and Penicillium taxa shared a strong positive relationship in CDI patients and together formed negative co-occurring relationships with several bacterial taxa, including the Oscillospira, Comamonadaceae, Microbacteriaceae, and Cytophagaceae. The investigators identified new pathways associated with C. difficile infections. Those pathways pointed to still other bacterial species, including Escherichia coli that may contribute to the dysbiosis, or imbalance among bacterial species in the gut, associated with C. difficile.

David B. Stewart, MD, a surgeon and first author of the study, said, “The development of C. difficile infection is apparently influenced both by bacterial pathogens and fungi particular to this disease. Until now, fungi have been understudied and under-appreciated in the gut microbiome.” The study was published on August 28, 2019, in the journal mSphere.

Related Links:
University of Arizona


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
New
Portable POCT Blood Gas Analyzer
BD100
Thyroid Test
Anti-Thyroid EIA Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: iStock

Prehospital Blood Test Could Reduce Emergency Transfers for Chest Pain

Chest pain leads to ambulance transport to an emergency department for about 95% of patients, although only a minority have a serious cardiac condition. Troponin testing helps assess heart muscle damage,... Read more

Molecular Diagnostics

view channel
Image: The method combines metagenomic sequencing with computational filtering to identify likely disease-causing bacteria and viruses (Image Credit: iStock)

Computational Filters Enhance Metagenomic Detection of Meningitis and Encephalitis

Infections of the central nervous system, such as meningitis and encephalitis, can be severe and require prompt diagnosis and treatment. Clinicians typically evaluate cerebrospinal fluid alongside symptoms... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.